| Date |
Heure |
Source |
Titre |
|---|
| 30/11/2023 | 23:00 | BW | FDA Grants Priority Review to Merck’s Application for.. |
| 29/11/2023 | 15:00 | BW | AWS and Accenture Help Merck Use Cloud Technology to Reduce.. |
| 28/11/2023 | 22:51 | EDGAR2 | Form 8-K - Current report |
| 28/11/2023 | 20:10 | DJN | Merck Raises Quarterly Dividend 5.5% To 77 Cents |
| 28/11/2023 | 19:17 | BW | Merck Announces First-Quarter 2024 Dividend |
| 28/11/2023 | 12:45 | BW | Merck’s V116, an Investigational, 21-valent Pneumococcal.. |
| 21/11/2023 | 12:45 | BW | Merck to Acquire Caraway Therapeutics, Inc. |
| 20/11/2023 | 12:45 | BW | Merck to Participate in the 6th Annual Evercore ISI.. |
| 17/11/2023 | 13:45 | IHMARKETNEWS | Friday’s Wall Street Highlights: Applied Materials,.. |
| 16/11/2023 | 23:40 | BW | FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus.. |
| 13/11/2023 | 13:36 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/11/2023 | 14:35 | DJN | Merck Gets CHMP Backing for Keytruda in Biliary Tract Cancer |
| 10/11/2023 | 13:40 | BW | Merck Receives Positive EU CHMP Opinion for KEYTRUDA®.. |
| 09/11/2023 | 23:05 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 09/11/2023 | 15:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 08/11/2023 | 22:38 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 08/11/2023 | 12:45 | BW | Merck to Participate in the Jefferies London Healthcare.. |
| 03/11/2023 | 21:10 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 01/11/2023 | 20:49 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 01/11/2023 | 11:50 | BW | Merck to Participate in the UBS BioPharma Conference |
| 01/11/2023 | 11:45 | BW | FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus.. |
| 01/11/2023 | 11:30 | BW | KEYTRUDA® (pembrolizumab) Significantly Improved Overall.. |
| 31/10/2023 | 16:08 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 30/10/2023 | 13:45 | IHNW | Can Diabetes, Weight-Loss Drugs Get Even Better? |
| 26/10/2023 | 14:30 | DJFR | Merck a vu son bénéfice net augmenter au T3, grâce à un bond.. |
| 26/10/2023 | 14:05 | DJN | Merck 3Q Profit Rose as Sales of Breast Cancer Treatment.. |
| 26/10/2023 | 13:08 | IHMARKETNEWS | Thursday’s Wall Street Highlights: Ford, Morgan Stanley,.. |
| 26/10/2023 | 12:38 | EDGAR2 | Form 8-K - Current report |
| 26/10/2023 | 12:30 | BW | Merck Announces Third-Quarter 2023 Financial Results |
| 25/10/2023 | 13:30 | PRNCA | KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) is.. |
| 22/10/2023 | 16:30 | BW | KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab.. |
| 21/10/2023 | 14:45 | BW | Merck’s WELIREG® (belzutifan) Significantly Improved.. |
| 20/10/2023 | 20:37 | DJN | Trending: Merck, Daiichi Sankyo Sign Development,.. |
| 20/10/2023 | 16:00 | BW | Merck’s KEYTRUDA® (pembrolizumab) Plus Concurrent.. |
| 20/10/2023 | 14:02 | BW | Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed.. |
| 20/10/2023 | 14:01 | BW | KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy.. |
| 20/10/2023 | 14:00 | BW | KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery.. |
| 20/10/2023 | 13:22 | IHMARKETNEWS | Friday’s Wall Street Highlights: SolarEdge, Intuitive.. |
| 20/10/2023 | 09:05 | DJFR | Merck et Daiichi Sankyo s'allient pour développer et.. |
| 20/10/2023 | 02:30 | DJN | Merck, Daiichi Sankyo Ink Commercialization Deal for Up to.. |
| 20/10/2023 | 01:30 | BW | Daiichi Sankyo and Merck Announce Global Development and.. |
| 17/10/2023 | 12:45 | BW | Merck Receives Positive EU CHMP Opinion for PREVYMIS® for.. |
| 17/10/2023 | 01:55 | DJN | Merck Gets FDA Approval for Resectable Lung Cancer Treatment.. |
| 17/10/2023 | 01:00 | BW | FDA Approves KEYTRUDA® (pembrolizumab) for Treatment of.. |
| 16/10/2023 | 12:45 | BW | European Commission Approves KEYTRUDA® (pembrolizumab) as.. |
| 13/10/2023 | 13:45 | BW | Merck Receives Positive EU CHMP Opinion for KEYTRUDA®.. |
| 10/10/2023 | 13:17 | DJN | Merck: Phase 3 Keytruda Study Hits Second Goal in Non-Small.. |
| 10/10/2023 | 12:45 | BW | Merck Highlights Innovative Oncology Portfolio and Pipeline.. |
| 10/10/2023 | 12:30 | BW | Merck Announces Pivotal KEYNOTE-671 Trial Meets Dual Primary.. |
| 05/10/2023 | 13:47 | DJN | Merck Keytruda Study Hits Key Goal in Advanced Bladder.. |
Donnée du Marché
Donnée du Marché
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
